DHX57 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.512600E-01
Normal-vs-Stage2
2.479200E-01
Normal-vs-Stage3
3.185800E-02
Normal-vs-Stage4
9.828600E-01
Stage1-vs-Stage2
3.078800E-01
Stage1-vs-Stage3
4.357500E-02
Stage1-vs-Stage4
6.349600E-01
Stage2-vs-Stage3
1.052370E-01
Stage2-vs-Stage4
1.770640E-01
Stage3-vs-Stage4
3.441600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.236800E-01
Normal-vs-AfricanAmerican
4.020600E-01
Normal-vs-Asian
4.371800E-02
Caucasian-vs-AfricanAmerican
8.842400E-01
Caucasian-vs-Asian
9.739600E-02
AfricanAmerican-vs-Asian
1.935030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.562200E-01
Normal-vs-Female
3.567000E-01
Male-vs-Female
3.368200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.362800E-01
Normal-vs-Age(41-60Yrs)
5.202400E-01
Normal-vs-Age(61-80Yrs)
2.105200E-01
Normal-vs-Age(81-100Yrs)
3.628800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.732000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.745800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.812200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.380110E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.623200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.376000E-01
Normal-vs-Daily Drinker
9.629800E-02
Normal-vs-Weekly Drinker
1.576630E-01
Normal-vs-Occasional Drinker
5.032400E-01
Normal-vs-Social Drinker
5.426400E-01
Non Drinker-vs-Daily Drinker
6.361800E-01
Non Drinker-vs-Weekly Drinker
9.379800E-01
Non Drinker-vs-Occasional Drinker
2.594200E-01
Non Drinker-vs-Social Drinker
2.309800E-01
Daily Drinker-vs-Weekly Drinker
7.206600E-01
Daily Drinker-vs-Occasional Drinker
1.034590E-01
Daily Drinker-vs-Social Drinker
8.737500E-02
Weekly Drinker-vs-Occasional Drinker
2.637000E-01
Weekly Drinker-vs-Social Drinker
2.241800E-01
Occasional Drinker-vs-Social Drinker
8.992800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.031000E-01
Normal-vs-Grade 2
6.220000E-01
Normal-vs-Grade 3
5.800400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.490400E-01
Grade 1-vs-Grade 3
5.907400E-01
Grade 1-vs-Grade 4
2.031000E-01
Grade 2-vs-Grade 3
3.061000E-01
Grade 2-vs-Grade 4
6.220000E-01
Grade 3-vs-Grade 4
5.800400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.040200E-01
Normal-vs-NonDiabetic
2.494200E-01
Diabetic-vs-NonDiabetic
3.941600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.401620E-01
Normal-vs-NoPancreatitis
2.619400E-01
Pancreatitis-vs-NoPancreatitis
5.368800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.659200E-01
Normal-vs-N1
2.702800E-01
N0-vs-N1
5.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.431400E-01
Normal-vs-TP53-NonMutant
6.186400E-01
TP53-Mutant-vs-TP53-NonMutant
5.874200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
